PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.\', \'State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences & University of Chinese Academy of Sciences, Beijing, 100101, China.\', \'Hubei University of Medicine, Shiyan, 442000, China.\', \'Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China.\', \'Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China.\', \'Guizhou University School of Medicine, Guiyang, 550025, China.\', \'School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 100029, China.\', \'State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. gbzhou@cicams.ac.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s11684-021-0837-6
?:hasPublicationType
?:journal
  • Frontiers of medicine
is ?:pmid of
?:pmid
?:pmid
  • 33511555
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.913
?:rankingScore_hIndex
  • 25
is ?:relation_isRelatedTo_publication of
?:title
  • Degradation of SARS-CoV-2 receptor ACE2 by the E3 ubiquitin ligase Skp2 in lung epithelial cells.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all